Africa Resilience Initiative

Primary tabs

Sat, 2009-03-21 11:57 — mdmcdonald

The mission of this working group is to articulate and shape issues of resilience and sustainability on the continent of Africa as they may be implemented as reforms of current policies, as well as contemplate and make recommendations for more extensive critiques and proposals for national, provincial, and local systems transformation, as may be necessary or desirable beyond the scope of traditional reforms being undertaken by the current African national governments and local government proposals in Africa.

General Topic Tags:

Resilience

Problem, Solution, SitRep, or ?:

Other

Group:

Request group membership

Group description:

This working group is focused on developing an Africa Resilience Initiative to ensure resilience and sustainability for all Africans.

Group roles and permissions:

Use default roles and permissions

Group visibility:

Public - accessible to all site users

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Aboubacar Conte	admin	Anthony	bnorton	Carrielaj	Chisina Kapungu
ChrisAllen	craig.sevcik	Dr Ojia Adamolekun	efrost	Elhadj Drame	Grace Kim
Hadiatou Balde	jranck	Kathy Gilbeaux	mdmcdonald	MDMcDonald_me_com	mike kraft
njchapman	Norea	SmShako	TacarraB	Tjivekumba Kandjii

Request group membership

Email address for group

Ebola whole virus vaccine shown effective, safe in primates

Fri, 2015-03-27 11:01 — mike kraft

SCIENCE DAILY March 26, 2015

(Scroll down for complete paper.)
An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.

The vaccine, described today (March 26, 2015) in the journal Science, was developed by a group led by Yoshihiro Kawaoka, a University of Wisconsin-Madison expert on avian influenza, Ebola and other viruses of medical importance. It differs from other Ebola vaccines because as an inactivated whole virus vaccine, it primes the host immune system with the full complement of Ebola viral proteins and genes, potentially conferring greater protection.

"In terms of efficacy, this affords excellent protection," explains Kawaoka, a professor of pathobiological sciences in the UW-Madison School of Veterinary Medicine and who also holds a faculty appointment at the University of Tokyo. "It is also a very safe vaccine."

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ebola whole virus vaccine shown effective, safe in primates
Log in or register to post comments

Two experimental Ebola vaccines pass safety test in African trial

Fri, 2015-03-27 10:03 — mike kraft

REUTERS by Sharon Begley March 26, 2015

NEW YORK - Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said on Thursday.

The two vaccines, each given in a single injection, are being tested for safety and efficacy on more than 600 people in Liberia in a mid-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases, a branch of NIH.

The Ebola epidemic that began in West Africa one year ago has killed more than 10,200 people, but a decline in new cases in the most affected countries, Liberia, Guinea and Sierra Leone, has led to hopes that it may be ending.

Based on the encouraging safety results, the study may now advance to the next phase of efficacy testing, in which additional volunteers are injected with the GSK vaccine, the NewLink vaccine, or a dummy shot and assessed to see whether their immune system responds by producing anti-Ebola antibodies.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Two experimental Ebola vaccines pass safety test in African trial
Log in or register to post comments

Ebola virus not mutating as quickly as thought

Thu, 2015-03-26 16:17 — mike kraft

SCIENCE NEWS by Ashley Yaeger March 26, 2015

(Scroll down for full study.)

The virus causing the current Ebola epidemic in West Africa is not evolving as quickly as some scientists had suggested.

REGULAR RATE A genetic analysis suggests that the Ebola virus, shown here in orange, is not evolving as fast as expected.

In a paper last August, researchers reported that the virus (Zaire ebolavirus) was altering its genes almost twice as fast as it had during previous Ebola outbreaks in Central Africa (SN: 9/20/14, p. 7). However, a new genetic analysis shows that the virus is mutating at roughly the same rate as in past outbreaks, researchers report online March 26 in Science. The finding suggests the virus has not become more virulent or transmissible during the West Africa outbreak.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ebola virus not mutating as quickly as thought
Log in or register to post comments

Ebola upsurge could undo progress in blink of an eye, warns expert

Thu, 2015-03-26 10:32 — mike kraft

THE GUARDIAN by Sam Jones March 26, 2015

Despite the massive push to bring the number of new Ebola cases down to zero as quickly as possible, there will inevitably be “flare-ups” that could reverse the overall downward trend and prove difficult to contain, the UN’s response co-ordinator has warned.

Dr David Nabarro, the UN’s special envoy for Ebola, said the huge medical, administrative and logistical operation to fight the disease could still be set back by individuals ignoring official advice.

“There will be flare-ups, there will be disappointments; there will be people who evade quarantine – because nobody likes being told to stay put – there will be people who choose not to declare that they’ve got a relative ill, there will be people who get ill and just misdiagnose themselves,” he said....

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ebola upsurge could undo progress in blink of an eye, warns expert
Log in or register to post comments

How Did Ebola Volunteers Know Where To Go In Liberia? Crowdsourcing!

Thu, 2015-03-26 09:04 — mike kraft

NATIONAL PUBLIC RADIO by Poncie Rutsch March 25, 2015
From more than 900 miles away, Kpetermeni Siakor helped get volunteers to the right neighborhoods in his native Liberia during the height of the Ebola epidemic.

Kpetermeni Siakor (left), a Liberian who is studying in Ghana, used crowdsourcing software to help out during the Ebola epidemic. Courtesy of Ashesi University College

He did it with Ushahidi, crowdsourcing software that was developed in Kenya in 2008, when the country experienced a wave of post-election violence. The word Ushahidi means testimony in Swahili.

"The government had shut down internet connections and radio stations, so Ushahidi was born out of the need to let people know what is happening," says Siakor, 26. He's a computer science student at Ashesi University College in Accra, Ghana, and receives financial support from the MasterCard Foundation Scholars Program.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Read more about How Did Ebola Volunteers Know Where To Go In Liberia? Crowdsourcing!
1 comment
Log in or register to post comments

Dr. Gavin Macgregor-Skinner - Ebola - Health Organizations Slow to Respond

Thu, 2015-03-26 08:55 — Kathy Gilbeaux

CLICK HERE - RECORDED VIDEO - Dr. Gavin Macgregor-Skinner

ctvnews.ca - March 23, 2015

Public health emergency expert Dr. Gavin Macgregor-Skinner discusses a new report saying faster action would have stopped the spread of Ebola.

CLICK HERE - MSF REPORT AND RELATED INFORMATION

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Problem

Situation Report

Read more about Dr. Gavin Macgregor-Skinner - Ebola - Health Organizations Slow to Respond
Log in or register to post comments

Ebola Vaccine Trial Starts in Guinea

Thu, 2015-03-26 08:48 — mike kraft

TIME MAGAZINE by Alexandra Sifferlin March 25, 2015
An efficacy trial for an Ebola vaccine launched in Guinea on Wednesday.

A health worker prepares a vaccination on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus.

The vaccine, VSV-EBOV, was developed by the Public Health Agency of Canada and has already shown positive results in smaller safety trials. NewLink Genetics and Merck are collaborating on the vaccine, and the Guinean government and World Health Organization (WHO) are leading the trial, which is taking place in Basse-Guinée, a community where many Ebola cases spread.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Ebola Vaccine Trial Starts in Guinea
Log in or register to post comments

Ebola Death Rates Vary Widely by Age Group

Wed, 2015-03-25 21:33 — mike kraft

LIVE SCIENCE by Agata Blaszczak Boxe March 25, 2015

Young children who are infected with Ebola may be more likely to die from the virus than older children or adults who are infected, according to a new study.

In the study, researchers examined Ebola cases in children younger than 16 during the current outbreak in Guinea, Liberia and Sierra Leone, and compared them with adult cases. They found that the outbreak's death rate has been higher among younger children than among older children and adults.

The disease has killed about 90 percent of infected children under age 1, and about 80 percent of kids ages 1 to 4 who have been infected. Older children who have been infected with Ebola may have a much better chance of surviving....

"The very youngest of children — neonates —appear to have the worst outcomes from Ebola," study co-author Dr. Robert Fowler, an associate professor of critical-care medicine at the University of Toronto, said in a statement. (Neonates, or newborns, are babies younger than 1 month.)

Country / Region Tags:

General Topic Tags: